These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3057302)

  • 1. Little or no induction of hyperglycemia by 2-deoxy-D-glucose in hereditary blind microphthalmic rats.
    Nagai K; Sekitani M; Otani K; Nakagawa H
    Life Sci; 1988; 43(20):1575-82. PubMed ID: 3057302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary suppression of the hyperglycemic response to 2-deoxy-D-glucose by blinding.
    Yamamoto H; Nagai K; Nakagawa H
    Chronobiol Int; 1988; 5(1):37-46. PubMed ID: 3370714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bilateral lesions of the suprachiasmatic nucleus on hyperglycemia caused by 2-deoxy-D-glucose and vasoactive intestinal peptide in rats.
    Chun SJ; Niijima A; Nagai N; Nagai K
    Brain Res; 1998 Nov; 809(2):165-74. PubMed ID: 9853107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orbital enucleation on glucose homeostasis and morphology of the suprachiasmatic nucleus.
    Nagai N; Nagai K; Nakagawa H
    Brain Res; 1992 Sep; 589(2):243-52. PubMed ID: 1393592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-D-glucose in rats.
    Shima T; Chun SJ; Niijima A; Bizot-Espiard JG; Guardiola-Lemaitre B; Hosokawa M; Nagai K
    Neurosci Lett; 1997 Apr; 226(2):119-22. PubMed ID: 9159504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions involving the suprachiasmatic nucleus eliminate the glucagon response to intracranial injection of 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Endocrinology; 1985 Aug; 117(2):468-73. PubMed ID: 3893985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral lesions involving the suprachiasmatic nucleus suppress hyperglycemia due to peripheral administration of 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Horm Metab Res; 1986 Nov; 18(11):788-9. PubMed ID: 3539740
    [No Abstract]   [Full Text] [Related]  

  • 8. Circadian rhythms and energy metabolism with special reference to the suprachiasmatic nucleus.
    Nagai K; Nagai N; Sugahara K; Niijima A; Nakagawa H
    Neurosci Biobehav Rev; 1994; 18(4):579-84. PubMed ID: 7708372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of cerebral neurotensin in hyperglycemic response caused by 2-deoxy-D-glucose in rats.
    Chun SJ; Niijima A; Shimizu K; Nagai K
    Neurosci Lett; 1995 Dec; 201(3):191-4. PubMed ID: 8786837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permissive effect of VIP on the hyperglycemic response induced by 2-deoxy-D-glucose.
    Shimizu K; Hibino H; Komenami N; Nagai N; Nagai K; Nakagawa H
    Neurosci Lett; 1994 Jul; 175(1-2):157-60. PubMed ID: 7970200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E928-33. PubMed ID: 2904768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral lesions of the SCN abolish lipolytic and hyperphagic responses to 2DG.
    Yamamoto H; Nagai K; Nakagawa H
    Physiol Behav; 1984 Jun; 32(6):1017-20. PubMed ID: 6494299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of infusion of vasoactive intestinal peptide (VIP)-antisense oligodeoxynucleotide into the third cerebral ventricle above the hypothalamic suprachiasmatic nucleus on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in rats.
    Chun S; Niijima A; Shima T; Okada M; Nagai K
    Neurosci Lett; 1998 Dec; 257(3):135-8. PubMed ID: 9870338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced increase in plasma renin activity on water-deprivation in blind hereditary microphthalmic rats.
    Nagai K; Stoynev AG; Nagai N; Nakagawa H
    Neurosci Lett; 1993 Jan; 149(2):217-20. PubMed ID: 8474696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of vasopressin on the hyperglycemic response to intracranial injection of 2-deoxy-D-glucose.
    Nagai N; Nagai K; Takezawa K; Chun SJ; Nakagawa H
    Neurosci Lett; 1995 May; 190(3):187-90. PubMed ID: 7637890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of VIP-neurons in the hypothalamic suprachiasmatic nucleus in the control of blood glucose].
    Nagai K
    Nihon Yakurigaku Zasshi; 2004 Apr; 123(4):253-60. PubMed ID: 15056940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves.
    Nagai K; Niijima A; Yamano T; Otani H; Okumra N; Tsuruoka N; Nakai M; Kiso Y
    Exp Biol Med (Maywood); 2003 Nov; 228(10):1138-45. PubMed ID: 14610252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding in response to insulin but not to 2-deoxy-D-glucose in the hamster.
    Ritter RC; Balch OK
    Am J Physiol; 1978 Jan; 234(1):E20-4. PubMed ID: 623243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucagon in macronutrient self-selection: glucagon-enhanced protein intake.
    Nagai K; Thibault L; Nishikawa K; Hashida A; Ootani K; Nakagawa H
    Brain Res Bull; 1991; 27(3-4):409-15. PubMed ID: 1959038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.